Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.054 | 0.7 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |